跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Augmentin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Augmentin
Approved
STANDARD
Augmentin
Glaxo Wellcome Production
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
07de28c2ff5669e6
Company
Glaxo Wellcome Production
Type
Standard
Approval Details
Approval Id
07de28c2ff5669e6
Drug Approval Philippines Name
Augmentin
Product Name
Augmentin
Registration Number
DRP-6476
Brand Name
Augmentin
Generic Name
Co-Amoxiclav
Dosage Form
Powder for Oral Suspension
Dosage Strength
156.25 mg/5 mL
Manufacturer
Glaxo Wellcome Production
Importer
GlaxoSmithKline Philippines, Inc.
Distributor
GlaxoSmithKline Philippines, Inc.
Company Detail Path
/organization/glaxo-wellcome-production
Issuance Date
19 October 2023
Expiry Date
19 October 2028
Pharmacologic Category
Antibacterial (Penicillin)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
07de28c2ff5669e6
Type
Standard
Back to Philippines FDA Approvals